Here are five things to know:
1. In 2015, Mr. Gorsuch denied a woman the right to sue Dublin-based Medtronic for injuries she claimed were caused by the company’s Infuse bone graft’s off-label promotion.
2. Mr. Gorsuch’s ruling applies the restriction to situations where devices were used in non-FDA-approved ways.
3. His opinion in rooted in the notion that state law can’t impose new requirements on FDA-approved medical devices, as he said, “A state’s judgment that a device is unsafe for a particular off-label use could require design changes that adversely affect the device’s safety for on-label uses.”
4. Should Mr. Gorsuch be confirmed, he is expected to bring similar beliefs to Supreme Court cases.
5. Physicians aren’t legally obligated to warn patients if a device is used in an off-label manner. Technically, once the FDA approves a device for a single use, physicians and patients may use it however they wish.
More device articles:
OrthAlign commercially launches UniAlign: 3 highlights
Amend Surgical earns FDA clearance for NanoFUSE BA: 4 things to know
$33.2B medical device outsourcing market to grow at a CAGR of 11.5% — 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
